Novozymes Berlin Competitors and Similar CompaniesClear all
Novozymes Berlin's competitors and similar companies include InProcess-LSP, Reliance Life Sciences and CoA Therapeutics.
 Novozymes Berlin Novozymes Berlin (formerly known as OrganoBalance) is a biotechnology research and development company. |  InProcess-LSP InProcess-LSP is a company that offers analytical services and solutions for pharma, food, life sciences to support product and process development, and manufacturing. |  Reliance Life Sciences Reliance Life Sciences is a research-driven organization developing business opportunities in biotherapeutics, pharmaceuticals, clinical research services, regenerative medicine, and molecular medicine. |  CoA Therapeutics CoA Therapeutics is a biopharmaceutical company developing small-molecules designed to increase Coenzyme-A (CoA) levels in genetic disorders where CoA deficiency is implicated. | |
Founding Date | Founding Date 2001 | Founding Date 2014 | Founding Date 2001 | Founding Date 2018 |
Type | Type Subsidiary | Type Private | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations Berlin, DE HQ | Locations Oss, NL HQ Oss, NL | Locations Navi Mumbai, IN HQ Ahmedabad, IN Bengaluru, IN Kolkata, IN Lucknow, IN Ludhiana, IN New Delhi, IN see more | Locations San Francisco, US HQ |
Employees | Employees 3 | Employees 20 | Employees 1,2711% decrease | Employees 7 |
For sources of this data, please see the company profile
View Company Profiles
InProcess-LSP
HQ
Oss, NL
Employees
20
InProcess-LSP is a company that offers analytical services and solutions for pharma, food, life sciences to support product and process development, and manufacturing.
View companyReliance Life Sciences
HQ
Navi Mumbai, IN
Reliance Life Sciences is a research-driven organization developing business opportunities in biotherapeutics, pharmaceuticals, clinical research services, regenerative medicine, and molecular medicine.
View companyCoA Therapeutics
HQ
San Francisco, US
CoA Therapeutics is a biopharmaceutical company developing small-molecules designed to increase Coenzyme-A (CoA) levels in genetic disorders where CoA deficiency is implicated.
View company